Angiocrine Bioscience

0 followers


Angiocrine Bioscience is a private, clinical-stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions.

Industries

Employees

11-50

Links

Org chart

Paul Finnegan

Collapse
John K. Fraser
Chief Scientific Officer
Lee Landeen
Executive Director, Pre-clinical Development
Michael Ginsberg
Senior Director, Product Development
Margie Breneman
Senior Director, Project Management
Daniel J. Nolan
Director, External Research
Geoff Davis
President And CSO
Gayle Bresnahan
Director, Clinical Operations
Kathy K. Park
Associate Director Clinical Operations